Dynavax Technologies | 10-Q: Quarterly report
Dynavax Technologies | 8-K: Dynavax Reports First Quarter 2024 Financial Results and Provides Business Updates
Dynavax Technologies | DEFA14A: Others
Dynavax Technologies | DEFA14A: Others
Dynavax Technologies | ARS: Annual Report to Security Holders
Dynavax Technologies | DEF 14A: Definitive information statements
Dynavax Technologies | 3: Initial statement of beneficial ownership of securities-Officer Slebir John L
Dynavax Technologies | 8-K: Current report
Dynavax Technologies | 4: Statement of changes in beneficial ownership of securities-Officer Burgess Justin
Dynavax Technologies | 8-K: Current report
Dynavax Technologies | 4: Statement of changes in beneficial ownership of securities-Officer Burgess Justin
Dynavax Technologies | 144: Notice of proposed sale of securities pursuant to Rule 144
Dynavax Technologies | 10-K: Annual report
Dynavax Technologies | 8-K: Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance
Dynavax Technologies | 4: Statement of changes in beneficial ownership of securities-Officer Novack David F
Dynavax Technologies | 4: Statement of changes in beneficial ownership of securities-Officer Spencer Ryan
Dynavax Technologies | 4: Statement of changes in beneficial ownership of securities-Officer MacDonald Kelly
Dynavax Technologies | 4: Statement of changes in beneficial ownership of securities-Officer Burgess Justin
Dynavax Technologies | 4: Statement of changes in beneficial ownership of securities-Officer Janssen Robert
Dynavax Technologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(5.49%),Deep Track Biotechnology Master Fund, Ltd.(5.49%), etc.
No Data